EQ-5D-3L Decrements by Diabetes Complications and Comorbidities in China

Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
Yichen ZhangLizheng Shi

Abstract

Patients with type 2 diabetes have lower quality of life, which is further impaired by diabetes complications and comorbidities. This study aims to evaluate the impact of diabetes complications and comorbidities on EuroQol Five-Dimension Three-Level (EQ-5D-3L) scores among patients with type 2 diabetes with ongoing oral drug treatments in China. This retrospective cross-sectional analysis included 9570 patients with type 2 diabetes on oral drug treatments, who were enrolled from 75 hospitals in nine cities in China. Patient characteristics, including demographic data, health conditions, oral treatment history, and health insurance coverage, were collected through self-reported questionnaires. Health utility was measured by the EQ-5D-3L scale in the questionnaire and a Chinese version of the EQ-5D-3L scoring weights was applied in the analysis. The associations between complications and health utility were assessed using linear regression. A total of 7081 patients with complete survey data were included in the analytic sample; 3479 (49.13%) patients were female. The mean age was 59.6 years old, with a standard deviation (SD) of 12.64. The average duration with type 2 diabetes was 7.91 (SD = 6.22) years. A total of 5189 (73.28%) ...Continue Reading

References

Feb 13, 2009·Current Medical Research and Opinion·Changyu PanHui Tian
Mar 11, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Milton C WeinsteinAlistair McGuire
Apr 7, 2011·The Journal of Clinical Hypertension·Amanda N Long, Samuel Dagogo-Jack
Apr 25, 2012·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Huey-Fen Wang, Mei Chang Yeh
May 9, 2014·International Journal of Environmental Research and Public Health·Aliasghar A KiadaliriKatarina Steen Carlsson
Dec 3, 2014·Diabetes & Metabolic Syndrome·Sheikh Mohammed Shariful IslamAndreas Lechner
Apr 1, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Varun VaidyaJack Sheehan
Jan 23, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Alison HayesPhilip Clarke
May 13, 2018·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Chao YangXiaoyuan Bao
Mar 8, 2019·BMC Public Health·Wenhui MaoWen Chen

❮ Previous
Next ❯

Citations

Jun 14, 2020·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Chen-Wei PanPei Wang
Apr 27, 2021·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Hassan KaramiSomayeh Afshari
Jul 11, 2021·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Chiu Hang MokJianchao Quan
Jul 22, 2021·Journal of Comparative Effectiveness Research·Xuanqian XieAndrei Volodin

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.